IBOV 209,066.90 ▲ 1.38% IPSA 11,043.36 ▲ 0.17% IPC MEX 66,746.78 ▲ 1.06% MERVAL 2,828,027 ▼ 0.16% COLCAP 2,531.15 — 0.00% BVL PERÚ 60,956.11 ▼ 0.51% USD/BRL4.98▼ 0.05% USD/MXN18.24▼ 0.10% USD/CLP975.06— 0.00% USD/COP3,197▲ 0.10% USD/PEN3.45▲ 0.23% USD/ARS1,517▼ 0.02% USD/UYU40.18— 0.00% USD/PYG5,691— 0.00% USD/BOB11.69— 0.00% USD/DOP61.12▲ 0.56% USD/CRC449.86— 0.00% USD/GTQ7.64— 0.00% USD/HNL26.86— 0.00% USD/NIO36.62— 0.00% USD/VES874.61▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.77— 0.00% EUR/BRL5.57▲ 0.21% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 209,066.90 ▲ 1.38% IPSA 11,043.36 ▲ 0.17% IPC MEX 66,746.78 ▲ 1.06% MERVAL 2,828,027 ▼ 0.16% COLCAP 2,531.15 — 0.00% BVL PERÚ 60,956.11 ▼ 0.51% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, October 13, 2026

Covid-19: CDC confirms it keeps no records of cases with natural immunity re-infecting themselves or infecting others

By · November 16, 2021 · 2 min read
Covid-19: CDC confirms it keeps no records of cases with natural immunity re-infecting themselves or infecting others

RIO DE JANEIRO, BRAZIL – In response to a Freedom of Information Act (FOI) request, the U.S. Centers for Disease Control and Prevention (“CDC”) admitted that there are no documented cases of unvaccinated individuals who have been re-infected or transmitted Covid to another person after acquiring so-called “natural immunity.”

Attorney Brehm, whose firm Siri & Glimstad lists vaccine injury and exemptions among its specialties, had requested “documents reflecting any documented case of an individual who: (1) never received a COVID-19 vaccine; (2) became infected with COVID-19 once, recovered, and then became re-infected; and (3) transmitted SARS-CoV-2 to another person when re-infected.”

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The CDC responded in a letter dated Nov. 5. “A search of our records did not reveal any documents related to your request,” a CDC spokesperson responded. “CDC’s Emergency Operations Center (EOC) relayed that this information is not collected.”

While the response alone does not establish that no such cases exist, it could be taken as an indicator of health officials’ disinterest in the information that could undermine elected policies.

“Studies have found that vaccine-induced protection against Covid wanes at around six months (or potentially sooner),” Life Site News reported, “by contrast, a recent Yale study projected that natural immunity lasts three times longer.”

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Simon keeps Puerto Vallarta airport shut until Tuesday”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

In an article, Dr. Sebastian Rushworth, a Stockholm physician, discussed a recent Swedish study to determine how effective Covid injections are in protecting against Covid after more than a few months.

In total, 1,684,958 people were included in the study. The study authors identified who was “vaccinated” at the end of May 2021. The vaccinated people were then compared individually with people of the same age and sex and living in the same municipality who had not been “vaccinated.” They followed them until October to see if they developed Covid-19.

After the first two months from “vaccination,” there was a rapid decline in efficacy. At four to six months, the injections, across all types, only reduced the relative risk of infection by 48%.

“Governments had initially set the bar for approving vaccines with a 50% relative risk reduction. Therefore, if the trials had been required to run for six months before presenting results instead of only running for two months, then the vaccines would have been considered too ineffective to be worth bothering with and would never have been approved,” said Dr. Rushworth.

Rushworth added that “four to six months after injection, AstraZeneca was no longer doing anything to reduce risk … [and] at nine months, the Pfizer vaccine no longer offers any protection.”

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

Read More from The Rio Times

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.